Emergent BioSolutions EBS
NYSE EBS
$6.09 -0.01 (-0.16%)
As of: Nov 10, 2026 · 12:55 PM EST

Emergent BioSolutions (EBS) Current Taxes (2012 - 2026)

Updated

Emergent BioSolutions (EBS) reported Current Taxes of $4.3 million for Q3 2026, down 2.3% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Current Taxes (2012 - 2026) Analysis & Trends

At the end of FY2025, Emergent BioSolutions posted Current Taxes of $6.8 million, up 17.2% from FY2024.

  • By year, Current Taxes came in at $5.8 million in FY2024.
  • The Q3 2026 figure ranks as the lowest quarterly Current Taxes since Q3 2018.
  • Per Business Quant data, the three quarters before Q3 2026 came in at $4.4 million (Q2 2026), $7.2 million (Q1 2026) and $6.8 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 1.98 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 4.31 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 1.47 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 438.00 Mn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn 4.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.30 Mn
Jun 30, 2026 4.40 Mn
Mar 31, 2026 7.20 Mn
Dec 31, 2025 6.80 Mn
Dec 31, 2024 5.80 Mn
Dec 31, 2018 4.50 Mn
Sep 30, 2018 164,000.00
Jun 30, 2018 2.77 Mn
Sep 30, 2017 1.88 Mn
Dec 31, 2012 115,000.00
API Access

Emergent BioSolutions Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=EBS&period=max&api_key=YOUR_API_KEY